Summary
Updated Aug 31, 2026
Paul B. Manning files SEC Form 4 reports at Candel Therapeutics, Inc. (CADL). 11 SEC Form 4 filings on record going back to 2024, most recently on 1 July 2026. Most recent open-market trade: sold $812K of LQDA on 8 June 2026. Lifetime open-market purchases: $28.01M. Lifetime open-market sales: $31.74M. Historical track record: 5/5 stars across 5 tracked purchases.
Recent Transactions
20Every recent SEC Form 4 transaction Paul B. Manning has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 100% |
| 90-day win rate | 100% |
| Avg 5-day return | +35.63% |
| Avg 30-day return | +35.82% |
| Avg 90-day return | +33.20% |
| Best 30-day return | +59.38% |
Trading Pattern
InsiderAlpha's records for Paul B. Manning go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. The typical open-market purchase is $2.15M (13 buys totaling $28.01M). The largest single buy on record is $11.67M of VRCA in 2025. Sales side: 9 recorded sales totaling $31.74M, so the filing history runs sell-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul B. Manning files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephen M. Bloch - $118.66M of LQDA open-market activity in the last 12 months
- Roger Jeffs - $29.23M of LQDA open-market activity in the last 12 months
- Michael Kaseta - $14.62M of LQDA open-market activity in the last 12 months
- Rajeev Saggar - $10.37M of LQDA open-market activity in the last 12 months
- Jason Adair - $7.26M of LQDA open-market activity in the last 12 months
- Scott Moomaw - $6.78M of LQDA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Paul B. Manning?
Paul B. Manning is a corporate insider of Candel Therapeutics, Inc. (CADL). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Paul B. Manning submitted recently?
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Paul B. Manning been buying or selling stock?
Recorded transactions: 13 open-market purchases ($28.01M) and 9 open-market sales ($31.74M) across all tracked filings.
How accurate is Paul B. Manning's historical track record?
Across 5 tracked purchases, Paul B. Manning averaged +35.8% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Paul B. Manning's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Paul B. Manning and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial